Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; high potent products; and other products for oncology. Granules India Limited was founded in 1984 and is based in Hyderabad, India.

Revenue projections:

Revenue projections for GRANULES
Revenue projections for GRANULES

Investors may be wary of GRANULES as its revenues are expected to fall below the prior year's levels. A revenue decrease often leads to concerns about profitability, as it is likely to affect the company's bottom line, prompting investors to take a more cautious approach.

Financial Ratios:

currentRatio 1.555000
forwardPE 15.725918
debtToEquity 39.153000
earningsGrowth 0.173000
revenueGrowth 0.018000
grossMargins 0.585820
operatingMargins 0.159910
trailingEps 20.660000
forwardEps 0.000000

GRANULES's current ratio of 1.555 reflects its strong liquidity position. The company has enough cash reserves and current assets to service its short-term debt obligations, signaling that GRANULES is financially well-prepared to meet its liabilities without difficulty.
GRANULES's Forward PE being in a good range indicates the stock is priced well relative to its earnings. It is not overvalued, leaving space for future growth, making it an appealing option for investors interested in long-term value appreciation.

Price projections:

Price projections for GRANULES
Price projections for GRANULES

Price projections for GRANULES have been revised downward over time, signaling decreasing optimism about the company's outlook. Analysts appear to be adjusting their expectations as concerns about future performance grow.

Recommendation changes over time:

Recommendations trend for GRANULES
Recommendations trend for GRANULES


The analysts' recent buy bias for GRANULES indicates strong confidence in the stock's future performance. This could encourage more investors to view GRANULES as a worthwhile investment, positioning the company as a top choice for those seeking financial security and long-term growth opportunities.